Buckley Wealth Management LLC grew its position in CME Group Inc. (NASDAQ:CME – Free Report) by 25.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,243 shares of the financial services provider’s stock after purchasing an additional 852 shares during the period. Buckley Wealth Management LLC’s holdings in CME Group were worth $786,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. MayTech Global Investments LLC acquired a new stake in CME Group during the fourth quarter worth about $25,000. GW&K Investment Management LLC grew its holdings in CME Group by 153.3% during the fourth quarter. GW&K Investment Management LLC now owns 152 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 92 shares during the period. CoreCap Advisors LLC acquired a new stake in CME Group during the fourth quarter worth about $26,000. Power Corp of Canada acquired a new stake in CME Group during the first quarter worth about $26,000. Finally, Silicon Valley Capital Partners acquired a new stake in CME Group during the first quarter worth about $27,000. 85.69% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
CME has been the topic of several research analyst reports. Barclays raised their price objective on CME Group from $215.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, July 27th. Citigroup raised their price objective on CME Group from $210.00 to $215.00 and gave the company a “buy” rating in a report on Thursday, July 27th. Bank of America raised CME Group from an “underperform” rating to a “neutral” rating and raised their price objective for the company from $167.00 to $204.00 in a report on Wednesday, September 6th. Rosenblatt Securities raised their price objective on CME Group from $169.00 to $173.00 and gave the company a “sell” rating in a report on Thursday, July 27th. Finally, StockNews.com initiated coverage on CME Group in a report on Thursday, August 17th. They issued a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $211.00.
CME Group Trading Up 0.0 %
NASDAQ:CME traded up $0.01 on Monday, reaching $206.83. The company’s stock had a trading volume of 187,569 shares, compared to its average volume of 1,589,264. CME Group Inc. has a 12-month low of $166.54 and a 12-month high of $209.31. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market cap of $74.41 billion, a price-to-earnings ratio of 25.25, a price-to-earnings-growth ratio of 2.70 and a beta of 0.41. The stock has a 50 day moving average price of $199.29 and a 200 day moving average price of $189.75.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, July 26th. The financial services provider reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $0.10. CME Group had a return on equity of 11.30% and a net margin of 56.88%. The company had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter in the previous year, the business earned $1.97 earnings per share. The company’s revenue for the quarter was up 9.9% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc. will post 9.02 EPS for the current fiscal year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Friday, September 8th will be paid a $1.10 dividend. The ex-dividend date is Thursday, September 7th. This represents a $4.40 dividend on an annualized basis and a dividend yield of 2.13%. CME Group’s payout ratio is presently 53.72%.
Insider Activity
In other news, Director Daniel R. Glickman sold 750 shares of CME Group stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $206.09, for a total value of $154,567.50. Following the completion of the sale, the director now directly owns 14,658 shares of the company’s stock, valued at $3,020,867.22. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, Director Daniel R. Glickman sold 750 shares of the business’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $206.09, for a total transaction of $154,567.50. Following the completion of the transaction, the director now directly owns 14,658 shares of the company’s stock, valued at approximately $3,020,867.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 30,000 shares of the business’s stock in a transaction on Friday, August 18th. The stock was sold at an average price of $203.95, for a total value of $6,118,500.00. Following the transaction, the chief executive officer now directly owns 65,545 shares of the company’s stock, valued at $13,367,902.75. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 58,391 shares of company stock valued at $11,905,049. 0.30% of the stock is currently owned by corporate insiders.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- How to Read Stock Charts for Beginners
- 5 Reasons Mullen Automotive is About to Turn a Corner
- The 3 Best Blue-Chip Stocks to Buy Now
- Qualcomm and Apple Forge Ahead with New Modem Partnership
- What is the S&P/TSX Index?
- Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.